Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:PRG NYSE:RSI NASDAQ:UPST NASDAQ:VVOS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePRGAaron's$31.79+3.0%$33.67$23.50▼$50.12$1.22B1.79461,121 shs344,092 shsRSIRush Street Interactive$19.83+4.9%$20.49$9.54▼$22.65$4.32B1.871.50 million shs2.24 million shsUPSTUpstart$50.39+1.6%$62.56$31.40▼$96.43$4.77B2.288.10 million shs5.59 million shsVVOSVivos Therapeutics$3.18+0.3%$3.85$1.98▼$7.95$23.79M6.9521,508 shs274,185 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePRGAaron's+2.92%+3.28%-10.38%+12.44%-33.76%RSIRush Street Interactive+5.00%+10.45%-6.46%+35.31%+74.56%UPSTUpstart+1.59%-2.74%-20.12%-34.52%-6.81%VVOSVivos Therapeutics+0.32%+2.58%-8.36%-47.61%+29.27%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePRGAaron's$31.79+3.0%$33.67$23.50▼$50.12$1.22B1.79461,121 shs344,092 shsRSIRush Street Interactive$19.83+4.9%$20.49$9.54▼$22.65$4.32B1.871.50 million shs2.24 million shsUPSTUpstart$50.39+1.6%$62.56$31.40▼$96.43$4.77B2.288.10 million shs5.59 million shsVVOSVivos Therapeutics$3.18+0.3%$3.85$1.98▼$7.95$23.79M6.9521,508 shs274,185 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePRGAaron's+2.92%+3.28%-10.38%+12.44%-33.76%RSIRush Street Interactive+5.00%+10.45%-6.46%+35.31%+74.56%UPSTUpstart+1.59%-2.74%-20.12%-34.52%-6.81%VVOSVivos Therapeutics+0.32%+2.58%-8.36%-47.61%+29.27%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePRGAaron's 2.63Moderate Buy$41.5030.53% UpsideRSIRush Street Interactive 2.67Moderate Buy$19.33-2.50% DownsideUPSTUpstart 2.21Hold$79.6758.10% UpsideVVOSVivos Therapeutics 2.00Hold$4.9254.61% UpsideCurrent Analyst Ratings BreakdownLatest UPST, PRG, RSI, and VVOS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/13/2025RSIRush Street InteractiveJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy10/13/2025UPSTUpstartThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSell$78.00 ➝ $54.0010/12/2025RSIRush Street InteractiveJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$27.0010/10/2025PRGAaron'sBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell$27.0010/8/2025PRGAaron'sWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)10/8/2025RSIRush Street InteractiveWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)10/8/2025UPSTUpstartWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/8/2025VVOSVivos TherapeuticsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/29/2025RSIRush Street InteractiveZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold9/27/2025PRGAaron'sWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)9/27/2025RSIRush Street InteractiveWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)(Data available from 10/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPRGAaron's$2.46B0.51$45.42 per share0.70$15.93 per share2.00RSIRush Street Interactive$924.08M4.90$0.19 per share106.43$0.88 per share22.53UPSTUpstart$636.53M7.62N/AN/A$6.94 per share7.26VVOSVivos Therapeutics$15.03M1.59N/AN/A$1.35 per share2.36Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePRGAaron's$197.25M$5.066.287.70N/A8.53%22.54%9.98%10/22/2025 (Estimated)RSIRush Street Interactive$2.39M$0.2099.1555.08N/A2.48%16.53%8.25%10/29/2025 (Estimated)UPSTUpstart-$128.58M-$0.08N/A54.18N/A-0.75%-5.95%-1.75%11/4/2025 (Estimated)VVOSVivos Therapeutics-$11.14M-$1.68N/AN/AN/A-99.49%-232.76%-84.30%11/13/2025 (Estimated)Latest UPST, PRG, RSI, and VVOS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/4/2025Q3 2025UPSTUpstart$0.42N/AN/AN/A$280.79 millionN/A10/29/2025Q3 2025RSIRush Street Interactive$0.07N/AN/AN/A$264.60 millionN/A10/22/2025Q3 2025PRGAaron's$0.73N/AN/AN/A$586.11 millionN/A8/19/2025Q2 2025VVOSVivos Therapeutics-$0.39-$0.55-$0.16-$0.55$3.37 million$3.82 million8/5/2025Q2 2025UPSTUpstart$0.27$0.36+$0.09$0.05$225.35 million$257.29 million7/30/2025Q2 2025RSIRush Street Interactive$0.08$0.11+$0.03$0.12$248.98 million$269.22 million7/23/2025Q2 2025PRGAaron's$0.79$1.02+$0.23$0.95$586.25 million$604.66 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPRGAaron's$0.521.64%N/A10.28%2 YearsRSIRush Street InteractiveN/AN/AN/AN/AN/AUPSTUpstartN/AN/AN/AN/AN/AVVOSVivos TherapeuticsN/AN/AN/AN/AN/ALatest UPST, PRG, RSI, and VVOS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/6/2025PRGAaron'squarterly$0.131.63%8/19/20258/19/20259/4/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPRGAaron's0.895.712.82RSIRush Street InteractiveN/A1.871.87UPSTUpstartN/A0.430.43VVOSVivos Therapeutics1.691.051.05Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPRGAaron's97.92%RSIRush Street Interactive24.78%UPSTUpstart63.01%VVOSVivos Therapeutics26.35%Insider OwnershipCompanyInsider OwnershipPRGAaron's3.21%RSIRush Street Interactive56.89%UPSTUpstart16.67%VVOSVivos Therapeutics2.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePRGAaron's1,40339.54 million38.28 millionNot OptionableRSIRush Street Interactive470228.49 million98.50 millionNot OptionableUPSTUpstart1,19396.22 million80.18 millionOptionableVVOSVivos Therapeutics1607.50 million7.35 millionOptionableUPST, PRG, RSI, and VVOS HeadlinesRecent News About These CompaniesVivos Therapeutics announces additional data from use of Vivos DNA deviceSeptember 30, 2025 | msn.comVivos Therapeutics Reports Clinical Data Showing Significant Improvement in ADHD and OSA Symptoms in Children Using FDA-Cleared DNA ApplianceSeptember 30, 2025 | quiverquant.comQVivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA DeviceSeptember 30, 2025 | globenewswire.comVivos Therapeutics announces trial results in pediatric OSA treatmentSeptember 17, 2025 | msn.comVivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea TreatmentSeptember 17, 2025 | globenewswire.comVivos Therapeutics’ Earnings Call: Strategic Transition and GrowthAugust 31, 2025 | tipranks.comVivos Therapeutics, Inc. (VVOS) Q2 2025 Earnings Call TranscriptAugust 22, 2025 | seekingalpha.comVivos Therapeutics, Inc. (NASDAQ:VVOS) Q2 2025 Earnings Call TranscriptAugust 21, 2025 | msn.comVivos Reports 7% Sales DropAugust 21, 2025 | aol.comAVivos Therapeutics, Inc: Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational UpdateAugust 20, 2025 | finanznachrichten.deVivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational UpdateAugust 19, 2025 | globenewswire.comVivos Therapeutics, Inc. Announces Upcoming Release of Second Quarter 2025 Financial Results and Conference CallAugust 19, 2025 | quiverquant.comQVivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference CallAugust 19, 2025 | globenewswire.comVivos Therapeutics Delays Q2 2025 10-Q FilingAugust 14, 2025 | msn.comVivos Therapeutics Adds to Management Team to Support Expansion and GrowthJuly 30, 2025 | finance.yahoo.comVivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance - MorningstarJuly 2, 2025 | morningstar.comMVivos Therapeutics Inc. (VVOS) Stock Price Today - WSJJuly 2, 2025 | wsj.comVivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral ApplianceJuly 1, 2025 | taiwannews.com.twTVivos Therapeutics stock soars after Medicare approves VidaSleep oral applianceJuly 1, 2025 | in.investing.comVivos Therapeutics Shares Skyrocket After Medicare Greenlights VidaSleep Oral DeviceJuly 1, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesQualcomm’s RSI Just Hit Its High of the Year—Why That’s BullishBy Sam Quirke | September 24, 2025Alphabet: Time to Take Profits, Buy, or Wait for a Pullback?By Ryan Hasson | September 25, 2025Sprouts, Darden Offer High-Upside Setups for Risk-TakersBy Sam Quirke | September 26, 2025Hershey vs. Mondelez: Which Stock Wins Chocolate Season?By Chris Markoch | September 25, 2025This ETF Weeds Out Small-Cap UnderperformersBy Jordan Chussler | September 29, 2025UPST, PRG, RSI, and VVOS Company DescriptionsAaron's NYSE:PRG$31.79 +0.91 (+2.96%) Closing price 10/14/2025 03:58 PM EasternExtended Trading$31.75 -0.04 (-0.12%) As of 10/14/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PROG Holdings, Inc. (NYSE:PRG) is a financial technology holding company based in Salt Lake City, Utah with three business segments: Progressive Leasing, which offers lease-to-own transactions primarily to credit-challenged consumers through e-commerce and point-of-sale retail partners, via online, mobile, and in-store solutions; Vive Financial, which provides consumers who may not qualify for traditional prime lending with a variety of second-look, revolving credit products through private label and branded credit cards; and Four Technologies, which provides consumers of all credit backgrounds Buy Now, Pay Later (BNPL) options through four interest-free installments via its platform, Four.Rush Street Interactive NYSE:RSI$19.83 +0.93 (+4.92%) Closing price 10/14/2025 03:58 PM EasternExtended Trading$19.94 +0.12 (+0.58%) As of 09:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rush Street Interactive, Inc. operates as an online casino and sports betting company in the United States, Canada, Mexico, and rest of Latin America. It provides real-money online casino, online and retail sports betting, and social gaming services. In addition, the company offers full suite of games comprising of bricks-and-mortar casinos, table games, and slot machines. The company markets its online casino and sports betting under BetRivers, PlaySugarHouse, and RushBet brands. Rush Street Interactive, Inc. was founded in 2012 and is headquartered in Chicago, Illinois.Upstart NASDAQ:UPST$50.39 +0.79 (+1.59%) Closing price 10/14/2025 04:00 PM EasternExtended Trading$51.95 +1.56 (+3.09%) As of 09:25 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Upstart Holdings, Inc., together with its subsidiaries, operates a cloud-based artificial intelligence (AI) lending platform in the United States. Its platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small dollar loans that connects consumer demand for loans to its to bank and credit unions. Upstart Holdings, Inc. was founded in 2012 and is headquartered in San Mateo, California.Vivos Therapeutics NASDAQ:VVOS$3.18 +0.01 (+0.32%) Closing price 10/14/2025 04:00 PM EasternExtended Trading$3.22 +0.04 (+1.26%) As of 09:25 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Healthcare Companies Insiders Are Buying NVIDIA Analysts Lift Targets: What It Means for the Stock Price Fastenal Stock Pulls Back in October—Is It Time to Buy FAST? 5 Stocks and ETFs to Weather Volatility as Trade Tensions Rise Why Congress Is Buying Intuitive Surgical Ahead of Earnings D-Wave: Reevaluating the Short Seller’s Case After the Downgrade 3 Dividend Hikes That Signal Renewed Strength in 2025 2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
